Neogen Corp
NEOG5.670USD
+0.210+3.85%
Handelsschluss 09/18, 16:00（ET）Kurse um 15 Minuten verzögert
1.23BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Neogen Corp Unternehmen
Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. Its Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues and general sanitation concerns. The Company’s Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services for the worldwide animal safety market.
Unternehmensinformationen
BörsenkürzelNEOG
Name des UnternehmensNeogen Corp
IPO-datumAug 23, 1989
CEOMr. Mikhael Nassif
Anzahl der mitarbeiter2974
WertpapierartOrdinary Share
GeschäftsjahresendeAug 23
Addresse620 Lesher Pl
StadtLANSING
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl48912
Telefon15173729200
Websitehttps://www.neogen.com/
BörsenkürzelNEOG
IPO-datumAug 23, 1989
CEOMr. Mikhael Nassif
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. James C. (Jim) Borel
Mr. James C. (Jim) Borel
Independent Chairman of the Board
Independent Chairman of the Board
90.47K
--
Mr. David Hartman Naemura
Mr. David Hartman Naemura
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
69.78K
-43.81%
Dr. Amy M. Rocklin, Ph.D.
Dr. Amy M. Rocklin, Ph.D.
Chief Legal & Compliance Officer
Chief Legal & Compliance Officer
44.17K
-45.09%
Dr. William T. (Bill) Boehm, Ph.D.
Dr. William T. (Bill) Boehm, Ph.D.
Independent Director
Independent Director
36.21K
+1.75%
Ms. Aashima Gupta
Ms. Aashima Gupta
Independent Director
Independent Director
21.92K
-21.70%
Dr. Catherine E. Woteki, Ph.D.
Dr. Catherine E. Woteki, Ph.D.
Independent Director
Independent Director
13.24K
--
Dr. Ronald D. Green, Ph.D.
Dr. Ronald D. Green, Ph.D.
Independent Director
Independent Director
12.78K
--
Ms. Andrea F. Wainer
Ms. Andrea F. Wainer
Independent Director
Independent Director
6.09K
--
Mr. Thierry Bernard
Mr. Thierry Bernard
Independent Director
Independent Director
5.62K
--
Mr. Mikhael Nassif
Mr. Mikhael Nassif
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. James C. (Jim) Borel
Mr. James C. (Jim) Borel
Independent Chairman of the Board
Independent Chairman of the Board
90.47K
--
Mr. David Hartman Naemura
Mr. David Hartman Naemura
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
69.78K
-43.81%
Dr. Amy M. Rocklin, Ph.D.
Dr. Amy M. Rocklin, Ph.D.
Chief Legal & Compliance Officer
Chief Legal & Compliance Officer
44.17K
-45.09%
Dr. William T. (Bill) Boehm, Ph.D.
Dr. William T. (Bill) Boehm, Ph.D.
Independent Director
Independent Director
36.21K
+1.75%
Ms. Aashima Gupta
Ms. Aashima Gupta
Independent Director
Independent Director
21.92K
-21.70%
Dr. Catherine E. Woteki, Ph.D.
Dr. Catherine E. Woteki, Ph.D.
Independent Director
Independent Director
13.24K
--
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Culture Media & Other
77.74M
35.18%
Bacterial & General Sanitation
39.88M
18.05%
Rodenticides, Insecticides & Disinfectants
35.64M
16.13%
Genomics Services
22.70M
10.27%
Natural Toxins, Allergens & Drug Residues
17.59M
7.96%
Andere
27.41M
12.41%
Nach RegionUSD
Name
Umsatz
Anteil
Domestic
115.36M
52.21%
International
105.61M
47.79%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Culture Media & Other
77.74M
35.18%
Bacterial & General Sanitation
39.88M
18.05%
Rodenticides, Insecticides & Disinfectants
35.64M
16.13%
Genomics Services
22.70M
10.27%
Natural Toxins, Allergens & Drug Residues
17.59M
7.96%
Andere
27.41M
12.41%
Aktionärsstatistik
Aktualisiert: Tue, Aug 19
Aktualisiert: Tue, Aug 19
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
12.68%
The Vanguard Group, Inc.
10.83%
Clarkston Capital Partners, LLC
6.45%
Gates Capital Management, Inc.
5.89%
Southpoint Capital Advisors LP
4.60%
Andere
59.55%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
12.68%
The Vanguard Group, Inc.
10.83%
Clarkston Capital Partners, LLC
6.45%
Gates Capital Management, Inc.
5.89%
Southpoint Capital Advisors LP
4.60%
Andere
59.55%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
48.43%
Investment Advisor/Hedge Fund
36.90%
Hedge Fund
15.85%
Research Firm
4.89%
Sovereign Wealth Fund
4.26%
Pension Fund
1.51%
Individual Investor
0.66%
Bank and Trust
0.55%
Private Equity
0.29%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
720
240.23M
110.60%
-42.75M
2025Q1
753
280.62M
129.30%
-9.42M
2024Q4
764
265.86M
122.55%
-15.84M
2024Q3
778
258.29M
119.19%
-21.39M
2024Q2
791
255.45M
117.89%
-8.15M
2024Q1
783
241.86M
111.66%
-5.94M
2023Q4
783
234.38M
108.27%
-1.28M
2023Q3
770
225.33M
104.20%
-18.20M
2023Q2
761
232.20M
107.41%
-2.78M
2023Q1
759
225.00M
104.19%
-1.65M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
28.62M
13.19%
+5.44M
+23.46%
Mar 31, 2025
The Vanguard Group, Inc.
23.51M
10.83%
+1.91M
+8.86%
Mar 31, 2025
Clarkston Capital Partners, LLC
6.28M
2.89%
+3.41M
+118.93%
Mar 31, 2025
Gates Capital Management, Inc.
9.16M
4.22%
+9.16M
--
Mar 31, 2025
William Blair Investment Management, LLC
13.56M
6.25%
-787.83K
-5.49%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
8.44M
3.89%
+1.50M
+21.56%
Mar 31, 2025
Norges Bank Investment Management (NBIM)
14.81M
6.82%
-2.67M
-15.27%
Mar 31, 2025
State Street Global Advisors (US)
8.61M
3.97%
+282.73K
+3.40%
Mar 31, 2025
Mackenzie Investments
7.76M
3.57%
-67.86K
-0.87%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Sep 6
Aktualisiert: Sat, Sep 6
Name
Anteil
Federated Hermes MDT Small Cap Core ETF
0.48%
Invesco NASDAQ Future Gen 200 ETF
0.43%
Inspire Small/Mid Cap ESG ETF
0.24%
Invesco S&P SmallCap 600 Pure Value ETF
0.2%
Amplify Etho Climate Leadership U.S. ETF
0.17%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
0.1%
iShares ESG Select Screened S&P Small-Cap ETF
0.09%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.07%
JPMorgan BetaBuilders US Small Cap Equity ETF
0.06%
Proshares Ultra Russell 2000
0.04%
Mehr Anzeigen
Federated Hermes MDT Small Cap Core ETF
Anteil0.48%
Invesco NASDAQ Future Gen 200 ETF
Anteil0.43%
Inspire Small/Mid Cap ESG ETF
Anteil0.24%
Invesco S&P SmallCap 600 Pure Value ETF
Anteil0.2%
Amplify Etho Climate Leadership U.S. ETF
Anteil0.17%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
Anteil0.1%
iShares ESG Select Screened S&P Small-Cap ETF
Anteil0.09%
SPDR SSGA US Small Cap Low Volatility Index ETF
Anteil0.07%
JPMorgan BetaBuilders US Small Cap Equity ETF
Anteil0.06%
Proshares Ultra Russell 2000
Anteil0.04%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
May 12, 2021
Split
1→2
Datum
Art
Verhältnis
May 12, 2021
Split
1→2
